Oscar Health, Inc. (OSCR)
NYSE: OSCR · Real-Time Price · USD
13.03
-1.05 (-7.46%)
At close: Nov 20, 2025, 4:00 PM EST
12.80
-0.23 (-1.77%)
After-hours: Nov 20, 2025, 5:31 PM EST
Oscar Health Stock Forecast
Stock Price Forecast
The 7 analysts that cover Oscar Health stock have a consensus rating of "Sell" and an average price target of $13.14, which forecasts a 0.84% increase in the stock price over the next year. The lowest target is $11 and the highest is $17.
Price Target: $13.14 (+0.84%)
Analyst Consensus: Sell
Analyst Ratings
The average analyst rating for Oscar Health stock is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Hold | 2 | 1 | 2 | 2 | 3 | 3 |
| Sell | 2 | 4 | 4 | 4 | 4 | 3 |
| Strong Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Total | 5 | 7 | 7 | 7 | 8 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Sell Maintains $14 → $11 | Sell | Maintains | $14 → $11 | -15.58% | Nov 13, 2025 |
| Barclays | Barclays | Sell Maintains $11 → $13 | Sell | Maintains | $11 → $13 | -0.23% | Nov 10, 2025 |
| UBS | UBS | Strong Sell Maintains $11 → $12 | Strong Sell | Maintains | $11 → $12 | -7.90% | Nov 7, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Initiates $17 | Hold | Initiates | $17 | +30.47% | Oct 14, 2025 |
| Wells Fargo | Wells Fargo | Sell Maintains $10 → $14 | Sell | Maintains | $10 → $14 | +7.44% | Oct 7, 2025 |
Financial Forecast
Revenue This Year
12.28B
from 9.18B
Increased by 33.80%
Revenue Next Year
11.56B
from 12.28B
Decreased by -5.84%
EPS This Year
-1.47
from 0.10
EPS Next Year
-0.43
from -1.47
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 12.7B | 12.7B | ||
| Avg | 12.3B | 11.6B | ||
| Low | 11.7B | 10.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 38.6% | 3.7% | ||
| Avg | 33.8% | -5.8% | ||
| Low | 27.2% | -13.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -1.23 | 0.17 | ||
| Avg | -1.47 | -0.43 | ||
| Low | -1.87 | -1.04 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.